BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Best of BioWorld: Q1
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Novel lysosomal Pro-X carboxypeptidase inhibitors prepared by Merck & Co.
Nov. 29, 2011
Onglyza obtains E.U. approval for saxagliptin combination therapy
Nov. 29, 2011
New vasopressin V1A receptor antagonists disclosed by Roche
Nov. 29, 2011
Hanmi applies for E.U. orphan drug designation for LAPS-rhGH
Nov. 28, 2011
biOasis enters agreement with Shire Human Genetic Therapies
Nov. 28, 2011
Novel compounds for diabetes prepared by Chinese team
Nov. 28, 2011
Asahi Kasei Pharma launches Teribone in Japan
Nov. 25, 2011
Novel IBAT inhibitors disclosed by GlaxoSmithKline
Nov. 25, 2011
Mesoblast and FDA agree on adult stem cell trial in type 2 diabetes
Nov. 24, 2011
Takeda files NDA for fixed-dose tablet of alogliptin/metformin
Nov. 24, 2011
Previous
1
2
…
587
588
589
590
591
592
593
594
595
…
1792
1793
Next
RSS